...
首页> 外文期刊>Protein Expression and Purification >Construction, non-denaturing affinity purification, and characterization of baculovirally expressed human secretory leukocyte protease inhibitor
【24h】

Construction, non-denaturing affinity purification, and characterization of baculovirally expressed human secretory leukocyte protease inhibitor

机译:杆状病毒表达的人分泌型白细胞蛋白酶抑制剂的构建,非变性亲和纯化和表征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Secretory leukocyte protease inhibitor (SLPI) is a 11.7 kDa mucosal protein with potent anti-microbial, anti-inflammatory, and wound healing activities. Previous efforts to express and purify the non-glycosylated cationic protein as a recombinant protein in bacteria required extensive denaturation and renaturation to refold the disulfide-rich protein into its biologically active form, To overcome this limitation. we have expressed human SLPI as a polyhistidine-tagged protein (bvHisSLPI) using a recombinant baculovirus expression system. Studies were conducted to determine the timing of maximal protein production following baculovirus infection of 121 cells. The 16.4 kDa-tagged protein was then overexpressed in Sf21 cells following a 48-h infection with bvHisSLPI-encoding baculovirus, purified by nickel-chelating affinity chromatography under non-denaturing conditions, and analyzed by Coomassie-stained SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot. Purified bvHisSLPI was further characterized by enterokinase digestion to remove the polyhistidine tag from its N-terminus. In serine protease inhibition assays, purified bvHisSLPI blocked substrate cleavage by two serine proteases, chymotrypsin and cathepsin G, comparable to bacterially expressed SLPI, The baculovirus expression and affinity purification strategy described here will facilitate further studies of the structural and biological properties of this important multifunctional protein. (C) 2002 Elsevier Science (USA). All rights reserved. [References: 28]
机译:分泌型白细胞蛋白酶抑制剂(SLPI)是一种11.7 kDa的粘膜蛋白,具有有效的抗微生物,抗炎和伤口愈合活性。先前在细菌中表达和纯化非糖基化阳离子蛋白作为重组蛋白的努力需要广泛的变性和复性,才能将富含二硫键的蛋白重新折叠成其生物活性形式,以克服这一局限性。我们已经使用重组杆状病毒表达系统将人SLPI表达为多组氨酸标签蛋白(bvHisSLPI)。进行了研究以确定杆状病毒感染121细胞后最大蛋白质生产的时机。在用bvHisSLPI编码杆状病毒感染48小时后,在Sf21细胞中过表达16.4 kDa标记的蛋白,在非变性条件下通过镍螯合亲和色谱纯化,并通过考马斯染色SDS-聚丙烯酰胺凝胶电泳(SDS)进行分析-PAGE)和蛋白质印迹。纯化的bvHisSLPI的特征还在于肠激酶消化,以从其N末端去除多组氨酸标签。在丝氨酸蛋白酶抑制试验中,纯化的bvHisSLPI可以阻断两种丝氨酸蛋白酶(胰凝乳蛋白酶和组织蛋白酶G)对底物的裂解,与细菌表达的SLPI相当。此处描述的杆状病毒表达和亲和纯化策略将有助于对该重要多功能分子的结构和生物学特性进行进一步的研究。蛋白。 (C)2002 Elsevier Science(美国)。版权所有。 [参考:28]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号